Literature DB >> 16912329

Intra- and intersubtype alternative Pak2-activating structural motifs of human immunodeficiency virus type 1 Nef.

Eduardo O'Neill1, Laura L Baugh, Vladimir A Novitsky, Myron E Essex, J Victor Garcia.   

Abstract

The design of antiviral strategies against human immunodeficiency virus type 1 (HIV-1) has been largely derived from studies of subtype B viruses, although they constitute only 12% of infections worldwide. At 50% of all HIV-1 infections worldwide, subtype C viruses are the most predominant. Here, we present evidence that subtype C Nefs display functional Pak2-activating motifs that differ from those found in subtype B and E Nefs. The identification of multiple Pak2-activating structural motifs that singly affect one Nef activity revealed a functional plasticity that has implications for future drug and vaccine design aimed at HIV-1 Nef and its effects on the deregulation of the immune system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912329      PMCID: PMC1563850          DOI: 10.1128/JVI.00910-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Analysis of the SH3-binding region of HIV-1 nef: partial functional defects introduced by mutations in the polyproline helix and the hydrophobic pocket.

Authors:  H M Craig; M W Pandori; N L Riggs; D D Richman; J C Guatelli
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

2.  HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes.

Authors:  V Piguet; L Wan; C Borel; A Mangasarian; N Demaurex; G Thomas; D Trono
Journal:  Nat Cell Biol       Date:  2000-03       Impact factor: 28.824

3.  HIV-1 nomenclature proposal.

Authors:  D L Robertson; J P Anderson; J A Bradac; J K Carr; B Foley; R K Funkhouser; F Gao; B H Hahn; M L Kalish; C Kuiken; G H Learn; T Leitner; F McCutchan; S Osmanov; M Peeters; D Pieniazek; M Salminen; P M Sharp; S Wolinsky; B Korber
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

4.  Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.

Authors:  Eduardo O'Neill; Lillian S Kuo; John F Krisko; Diana R Tomchick; J Victor Garcia; John L Foster
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 5.  Human immunodeficiency viruses in the developing world.

Authors:  M Essex
Journal:  Adv Virus Res       Date:  1999       Impact factor: 9.937

Review 6.  Progress towards an HIV-1 subtype C vaccine.

Authors:  Joseph P Nkolola; Max Essex
Journal:  Vaccine       Date:  2005-08-15       Impact factor: 3.641

7.  A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2.

Authors:  Kristin Agopian; Bangdong L Wei; J Victor Garcia; Dana Gabuzda
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

8.  Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana.

Authors:  T Ndung'u; B Renjifo; V A Novitsky; M F McLane; S Gaolekwe; M Essex
Journal:  Virology       Date:  2000-12-20       Impact factor: 3.616

9.  Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design.

Authors:  V Novitsky; P O Flores-Villanueva; P Chigwedere; S Gaolekwe; H Bussman; G Sebetso; R Marlink; E J Yunis; M Essex
Journal:  Hum Immunol       Date:  2001-02       Impact factor: 2.850

10.  Lentivirus Nef specifically activates Pak2.

Authors:  V K Arora; R P Molina; J L Foster; J L Blakemore; J Chernoff; B L Fredericksen; J V Garcia
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

View more
  5 in total

Review 1.  Mechanisms of HIV-1 Nef function and intracellular signaling.

Authors:  John L Foster; Sarah J Denial; Brenda R S Temple; J Victor Garcia
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-19       Impact factor: 4.147

2.  Nef-mediated enhancement of cellular activation and human immunodeficiency virus type 1 replication in primary T cells is dependent on association with p21-activated kinase 2.

Authors:  Kevin C Olivieri; Joya Mukerji; Dana Gabuzda
Journal:  Retrovirology       Date:  2011-08-05       Impact factor: 4.602

Review 3.  HIV-1 Nef: at the crossroads.

Authors:  John L Foster; J Victor Garcia
Journal:  Retrovirology       Date:  2008-09-22       Impact factor: 4.602

4.  Primate lentiviral Nef proteins deregulate T-cell development by multiple mechanisms.

Authors:  Anouk Van Nuffel; Kevin K Ariën; Veronique Stove; Michael Schindler; Eduardo O'Neill; Jan Schmökel; Inge Van de Walle; Evelien Naessens; Hanne Vanderstraeten; Kathleen Van Landeghem; Tom Taghon; Kati Pulkkinen; Kalle Saksela; J Victor Garcia; Oliver T Fackler; Frank Kirchhoff; Bruno Verhasselt
Journal:  Retrovirology       Date:  2013-11-15       Impact factor: 4.602

5.  HIV-1 infection of CD4 T cells impairs antigen-specific B cell function.

Authors:  Sheetal Kaw; Swetha Ananth; Nikolaos Tsopoulidis; Katharina Morath; Bahar M Coban; Ralph Hohenberger; Olcay C Bulut; Florian Klein; Bettina Stolp; Oliver T Fackler
Journal:  EMBO J       Date:  2020-11-04       Impact factor: 14.012

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.